The ability of sorafenib to kill hepatoma cells was reduced by knock down of PDGFR and sorafenib (6 M) toxicity was suppressed by knock down of CD95 (Figure 4C)
The ability of sorafenib to kill hepatoma cells was reduced by knock down of PDGFR and sorafenib (6 M) toxicity…